Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-emptive Qutenza (capsaicin 8%) to prevent neuropathic pain after lower limb amputation
2012-001587-30Phase 4Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of capsaicin in Neuralgia and chronic pain (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Chronic pain at 12 weeks. Started Aug 2013; status: completed.
02
Drugs
capsaicin
03
Conditions
Neuralgiachronic pain
Beyond the preview
Go deeper on 2012-001587-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001587-30.